tm
Seeing Is Believing
tm
Seeing Is Believing
RAIN is currently covered by 6 analysts with an average price target of $6.94. This is a potential upside of $5.73 (473.55%) from yesterday's end of day stock price of $1.21.
Rain Therapeutics's activity chart (see below) currently has 6 price targets and 30 ratings on display. The stock rating distribution of RAIN is 66.67% BUY and 33.33% HOLD.
Analysts average stock forecasts to be materialized ratio is 17.62% with an average time for these price targets to be met of 59.86 days.
Highest price target for RAIN is $1.75, Lowest price target is $1, average price target is $6.94.
Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 18-Sep-2023. First documented stock forecast 18-May-2021.
Currently out of the existing stock ratings of RAIN, 16 are a BUY (66.67%), 8 are a HOLD (33.33%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
1
$-0.21 (-17.36%)
1.5
7 months 5 days ago
1/6 (16.67%)
$0.16 (19.05%)
28
Hold
1
$-0.21 (-17.36%)
17
10 months 18 days ago
1/5 (20%)
$-0.25 (-20.00%)
73
Hold
10 months 21 days ago
2/3 (66.67%)
$10.01 (111.35%)
90
Hold
1.75
$0.54 (44.63%)
12
11 months ago
1/5 (20%)
$0.51 (41.13%)
228
Hold
17
11 months ago
0/1 (0%)
$13.56 (394.19%)
What is RAIN (Rain Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on RAIN (Rain Therapeutics) with a proven track record?
Which analyst has the current lower performing score on RAIN (Rain Therapeutics) with a proven track record?
Which analyst has the most public recommendations on RAIN (Rain Therapeutics)?
Which analyst is the currently most bullish on RAIN (Rain Therapeutics)?
Which analyst is the currently most reserved on RAIN (Rain Therapeutics)?
